Drug intelligence / Profile preview

sulfanilamide

Development stage
Unknown
Lead developer
Bayer
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Topical, Intravaginal
01

Overview

Sulfanilamide is a synthetic sulfonamide antibacterial drug and one of the earliest antibiotics developed. It acts as a competitive inhibitor of the bacterial enzyme dihydropteroate synthase, blocking the use of para-aminobenzoic acid (PABA) in folic acid synthesis. This inhibition prevents bacteria from synthesizing folic acid, which is essential for their growth and replication. Sulfanilamide was historically significant in reducing infection-related mortality during World War II but is now rarely used systemically due to toxicity and the availability of more effective alternatives. Today, it is primarily used topically or intravaginally for infections such as vulvovaginal candidiasis caused by Candida albicans[1][2][4].

Brand names
AVC
Other names
p-amino-benzenesulfonamidesulphanilamide
02

Targets

DHPS (Dihydropteroate synthase)

Beyond the preview

Go deeper on sulfanilamide.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sulfanilamide.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call